SCO­TUS rais­es ques­tions over le­gal stand­ing in abor­tion pill case

WASH­ING­TON, DC – Supreme Court jus­tices ap­peared un­cer­tain on Tues­day that doc­tors and an­ti-abor­tion groups have stand­ing to chal­lenge the FDA’s cur­rent la­bel for the com­mon­ly used abor­tion pill mifepri­s­tone.

The Court is tasked with de­cid­ing whether to up­hold a Fifth Cir­cuit de­ci­sion re­vers­ing the FDA’s long-stand­ing pre­scrib­ing con­di­tions for mifepri­s­tone. While the drug has been ap­proved in the US for more than two decades, key la­bel changes in 2016 and 2021 have al­lowed the pill to be dis­trib­uted by mail and ex­tend­ed how late in­to preg­nan­cy it can be tak­en by three weeks.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER